MSBI:NASDAQMidland States Bancorp, Inc. analysis
Data as of Jul 16, 2026 - not real-time
- Latest price
- $31.70
- Risk: medium
- 7/10Medium risk
Summary
Midland States Bancorp (MSBI) is trading at $31.70, comfortably above its 20‑day SMA (30.44) and 50‑day SMA (28.97) while still below the 200‑day SMA (22.67), indicating a short‑term bullish bias within a longer‑term uptrend. Momentum signals are mixed: the RSI sits at 67, edging toward overbought territory, and the MACD histogram has turned negative with a bearish signal line crossover, while trading volume has been decreasing, suggesting waning short‑term enthusiasm. The stock offers an attractive 4.17% dividend yield, but the payout ratio exceeds 100%, raising concerns about sustainability. Valuation metrics are mixed – a trailing P/E of 26.4x outpaces the industry average of 18x, yet the forward P/E drops to 10.1x, and the DCF model implies a fair value far above the current price, creating a valuation paradox. Revenue growth remains robust at 14% YoY, and the forward EPS projection (3.14) more than doubles the trailing EPS (1.20), supporting a growth narrative. However, the bank’s beta (~0.8) and 30‑day volatility of nearly 25% signal higher price swings than the broader market, and the declining volume trend may limit liquidity in rapid moves. Recent material news is limited to a scheduled Q2 earnings release on July 23, providing little immediate catalyst. Overall, the stock sits at a crossroads between short‑term technical weakness and longer‑term growth fundamentals, with dividend appeal tempered by payout concerns.
Market outlook
Short term
< 1 yearNeutral
Key factors
- Price near resistance with bearish MACD crossover
- RSI approaching overbought levels
- Decreasing trading volume
Medium term
1–3 yearsNeutral
Key factors
- Strong revenue growth and improving forward earnings
- High dividend yield but unsustainable payout ratio
- Valuation disparity between trailing and forward P/E
Long term
> 3 yearsPositive
Key factors
- Long‑term growth prospects in loan and wealth‑management segments
- Potential price correction toward DCF‑derived intrinsic value
- Low beta indicating relative resilience in broader market moves
Key metrics
Financial health
Technical analysis
Valuation
Risk assessment
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.